24 June 2007 in BMC Surgery
Isolated hepatobiliary or pancreatic tuberculosis (TB) is rare and preoperative diagnosis is difficult. We reviewed our experience over a period two decades with this rare site of abdominal tuberculosis.
26 March 2007 in BMC Gastroenterology
Cystic artery pseudoaneurysm is a rare complication following cholecystitis. Its presentation with upper gastrointestinal hemorrhage (UGIH) is even rarer. Thirteen patients with cystic artery pseudoaneurysm have been reported in the literature but only 2 of them presented with UGIH alone.
1 February 2016 in Journal of Visceral Surgery
1 January 2013 in JSLS : Journal of the Society of Laparoscopic & Robotic Surgeons
SBSankar Prasad Bhattacharya
Sankar Prasad Bhattacharya
Endoclip migration into the common bile duct after laparoscopic cholecystectomy is a rare complication. Very few cases have been reported in the literature, mostly in the form of case reports. We report a case of Endoclip migration into the bile duct with stone formation 6 y after laparoscopic cholecystectomy. The patient presented with recurrent abdominal pain and intermittent jaundice for 6 mo. Diagnosis was suspected when a computed tomography scan of the abdomen showed a metallic density artifact in the lower end of the bile duct. The diagnosis was confirmed by endoscopic retrograde cholangiopancreatography. The patient was successfully managed by endoscopic stone and clip removal. Endoclip migration with biliary complications should be considered in the differential diagnosis of postcholecystectomy problems. The clinical manifestations and management are similar to that of noniatrogenic choledocholithiasis.
3 December 2019 in BMC Cancer
Background: Pancreatic ductal adenocarcinoma (PDAC) is considered as one of the most aggressive cancers lacking efficient early detection biomarkers. Circulating miRNAs are now being considered to have potency to be used as diagnostic and prognostic biomarkers in different diseases as well as cancers. In case of cancer, a fraction of the circulating miRNAs is actually derived from the tumour tissue. This fraction would function as stable biomarker for the disease and also would contribute to the understanding of the disease development. There are not many studies exploring this aspect in pancreatic cancer and even there is not much overlap of results between existing studies.Methods: In order to address that gap, we performed a miRNA microarray analysis to identify differentially expressed circulating miRNAs between PDAC patients and normal healthy individuals and also found two more similar datasets to perform a meta-analysis using a total of 182 PDAC patients and 170 normal, identifying a set of miRNAs significantly altered in patient serum. Next, we found five datasets studying miRNA expression profile in tumour tissues of PDAC patients as compared to normal pancreas and performed a second meta-analysis using data from a total of 183 pancreatic tumour and 47 normal pancreas to detect significantly deregulated miRNAs in pancreatic carcinoma. Comparison of these two lists and subsequent search for their target genes which were also deregulated in PDAC in inverse direction to miRNAs was done followed by investigation of their role in disease development.Results: We identified 21 miRNAs altered in both pancreatic tumour tissue and serum. While deciphering the functions of their target genes, we characterized key miR-Gene interactions perturbing the biological pathways. We identified important cancer related pathways, pancreas specific pathways, AGE-RAGE signaling, prolactin signaling and insulin resistance signaling pathways among the most affected ones. We also reported the possible involvement of crucial transcription factors in the process.Conclusions: Our study identified a unique meta-signature of 21 miRNAs capable of explaining pancreatic carcinogenesis and possibly holding the potential to act as biomarker for the disease detection which could be explored further.
1 February 2020 in Journal of Visceral Surgery